Our position in Finnish about the proposed #NATO#AI#quantum technologies.
Our position in Finnish on the proposed #Nato Center of Excellence on #AI and #Quantum technologies. We support Finland to seek the formation of such Center…
Our collaboration project EM4QS "Enhanced Middleware for Quantum Software" with the universities of Helsinki and Jyväskylä and other industry partners got funded! Stay tuned for updates on the progress. We believe there will be key findings for making quantum industrial.
Our partner #Quantastica added a pretty nice feature into their platform. Generating quantum circuits from classical code.
YouTube video by Quantastica
Republican Senator proposes a #Nato#AI#QuantumComputing and this might be our favorite proposal.
Good reminder from the Finnish authorities: it's time to prepare for post quantum encryption. Happy to help with the preparation.
Traficom muistuttaa: nyt on oikea aika aloittaa valmistautuminen kvanttiturvalliseen salaukseen
Tietomurroissa varastetut salatut tiedot voidaan murtaa tulevaisuudessa. Kvanttiturvallisia toteutuksia, kuten esimerkiksi Signal-viestisovellus, on jo tehty standardiluonnosten perusteella.
Couple of updates on interesting happenings in the quantum business. 1. The NIST standardization continues, but math is hard. A new vulnerability has been found and fixed. First movers need to beware. thecyberexpress.com/kyber-post-q...
The Kyber post-quantum key encapsulation vulnerability shows that code that appears secure can be undone by a compiler.
A short intro into a research project combining 6G and quantum topics where we are involved in with Nokia, VTT, and Cumucore.
The growth in the number of information network users frequently leads to congestion, causing delays and disruptions of service for users. At the same time, the increasing complexity of networks and t...
Today, we had another industry workshop this time focused on pharmaceuticals. The obvious molecular modelling use cases are important, but there is a lot more over the long term on handling the clinical data, modelling larger biological systems, and even optimising production and logistics.